Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inflammatory bowel disease reveals the kinase activity of KSR1
Richard Kolesnick, H. Rosie Xing
Richard Kolesnick, H. Rosie Xing
Published November 1, 2004
Citation Information: J Clin Invest. 2004;114(9):1233-1237. https://doi.org/10.1172/JCI23441.
View: Text | PDF
Commentary Article has an altmetric score of 6

Inflammatory bowel disease reveals the kinase activity of KSR1

  • Text
  • PDF
Abstract

Kinase suppressor of Ras-1 (KSR1) is a recently identified member of the EGFR–Ras–Raf-1–MAPK signaling pathway. A new study demonstrates that KSR1 protects intestinal epithelium from TNF-α–induced apoptosis, abrogating inflammatory bowel disease (IBD). Since its discovery, there has been disagreement as to whether KSR1 possesses intrinsic kinase activity. Using transgenic mouse models and genetically modified mouse colon epithelial cells, Polk and coworkers show that the kinase activity of KSR1 is off in normal colon epithelial cells, becoming activated only at the onset of IBD. They also provide strong evidence that KSR1 kinase activity is essential for anti-apoptotic protection of the intestinal epithelium. These new data in support of KSR1 as a kinase highlight an ongoing debate as to whether KSR1 does indeed serve as a specific kinase in transphosphorylating and transactivating c-Raf–1 toward MEK1.

Authors

Richard Kolesnick, H. Rosie Xing

×

Total citations by year

Year: 2021 2014 2013 2011 2009 2007 2006 Total
Citations: 1 1 1 5 1 1 2 12
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (12)

Title and authors Publication Year
Overexpression of pEGF improved the gut protective function of Clostridium butyricum partly through STAT3 signal pathway.
Ma M, Zhao Z, Liang Q, Shen H, Zhao Z, Chen Z, He R, Feng S, Cao D, Gan G, Ye H, Qiu W, Deng J, Ming F, Jia J, Sun C, Li J, Zhang L
Applied Microbiology and Biotechnology 2021
KSR1 regulates BRCA1 degradation and inhibits breast cancer growth
J Stebbing, H Zhang, Y Xu, LC Lit, AR Green, A Grothey, Y Lombardo, M Periyasamy, K Blighe, W Zhang, JA Shaw, IO Ellis, HJ Lenz, G Giamas
Oncogene 2014
SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1
Zhang H, Xu Y, Filipovic A, Lit LC, Koo CY, Stebbing J, Giamas G
British Journal of Cancer 2013
Raf family kinases: old dogs have learned new tricks
D Matallanas, M Birtwistle, D Romano, A Zebisch, J Rauch, A Kriegsheim, W Kolch
Genes & cancer 2011
Simulating EGFR-ERK Signaling Control by Scaffold Proteins KSR and MP1 Reveals Differential Ligand-Sensitivity Co-Regulated by Cbl-CIN85 and Endophilin
L Huang, CQ Pan, B Li, L Tucker-Kellogg, B Tidor, Y Chen, BC Low
PloS one 2011
KSR1 Is Overexpressed in Endometrial Carcinoma and Regulates Proliferation and TRAIL-Induced Apoptosis by Modulating FLIP Levels
D Llobet, N Eritja, M Domingo, L Bergada, C Mirantes, M Santacana, J Pallares, A Macià, A Yeramian, M Encinas, G Moreno-Bueno, J Palacios, RE Lewis, X Matias-Guiu, X Dolcet
The American Journal of Pathology 2011
Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections
Y Zhang, X Li, A Carpinteiro, JA Goettel, M Soddemann, E Gulbins
Nature Medicine 2011
Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF
Hu J, Yu H, Kornev AP, Zhao J, Filbert EL, Taylor SS, Shaw AS
Proceedings of the National Academy of Sciences 2011
Kinase suppressor of Ras transphosphorylates c-Raf-1
M Zafrullah, X Yin, A Haimovitz-Friedman, Z Fuks, R Kolesnick
Biochemical and Biophysical Research Communications 2009
Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamn D3 and is required for optimal cell differentiation
Wang X, Wang TT, White JH, Studzinski GP
Experimental Cell Research 2007
Induction of kinase suppressor of RAS-1(KSR-1) gene by1, α25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5′-flanking region
Wang X, Wang TT, White J, Studzinski G
Oncogene 2006
MAP kinase pathways: The first twenty years
Avruch J
Biochimica et Biophysica Acta 2006

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
Referenced in 1 Wikipedia pages
20 readers on Mendeley
1 readers on CiteULike
See more details